Vivos Therapeutics Inc
(VVOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 0 | 0 | 0 | 469 |
| Receivables | 0 | 0 | 0 | 956 |
| Other current assets | 0 | 0 | 0 | 559 |
| TOTAL | $0 | $0 | $0 | $1,984 |
| Non-Current Assets | ||||
| PPE Net | N/A | N/A | N/A | 1,642 |
| Other Non-Current Assets | 0 | 0 | 0 | 4,428 |
| TOTAL | $N/A | $N/A | $N/A | $6,070 |
| Total Assets | $0 | $0 | $0 | $7,552 |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 0 | 0 | 0 | 3,710 |
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 1,083 |
| Accrued Expenses | 0 | 0 | 0 | 1,353 |
| Other current liabilities | 0 | 0 | 0 | 2,948 |
| TOTAL | $0 | $0 | $0 | $9,094 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 1,401 |
| TOTAL | $N/A | $N/A | $N/A | $1,401 |
| Total Liabilities | $0 | $0 | $0 | $10,495 |
| Shareholders' Equity | ||||
| Common Shares | 0 | 0 | 0 | 1 |
| Retained earnings | 0 | 0 | 0 | -23,278 |
| TOTAL | $0 | $0 | $0 | $-2,943 |
| Total Liabilities And Equity | $0 | $0 | $0 | $7,552 |